Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Costain unveils £10m buyback as first-half profits rise

(Sharecast News) - Costain has announced a £10m share buyback programme as it reported higher profits for the first half on the back of improved margins and a better product mix. The British construction and engineering firm made an adjusted operating profit of £16.3m for the six months to 30 June, up 8.7% on last year, with the adjusted operating margin rising by 20 basis points to 2.5%.

This was driven mainly by an "improved performance in Transportation resulting from a better margin mix derived from newer contracts and increased volumes, and margin in Natural Resources, which has a greater mix of consultancy services", the company explained.

Looking ahead, Costain said it was on course to hit its margin targets over 2024 and 2025 of 3.5% and 4.5%, respectively.

Revenues over the first half totalled £639.3m, down 3.8% year-on-year as growth in Natural Resources was offset by declines in Transportation, where there were reductions in road volumes due to the completion of certain projects, and in rail due to the completion of main works at Gatwick Station.

"As a result of our strong performance and valued long-term relationships with our customers, we have increased our forward work position to a very healthy £4.3bn at the half year, with contract wins across all our sectors," said chief executive Alex Vaughan.

"As a result of our confidence in our long-term prospects, and our strong cash position, we have today announced a £10m share buyback which will commence with immediate effect."

Share this article

Related Sharecast Articles

Berenberg lowers target price on Impax Asset Management
(Sharecast News) - Analysts at Berenberg lowered their target price on Impax Asset Management from 620.0p to 560.0p on Tuesday but noted that outflows had started to slow.
GSK's Arexvy provides protection over three RSV seasons, trial shows
(Sharecast News) - GSK has announced positive results from a phase III trial of its Arexvy RSV vaccine, showing that just one dose of the treatment could help protect older adults at risk of RSV disease over three seasons.
S&U revenue up, profitability a challenge in first half
(Sharecast News) - Motor and property finance specialist S&U reported a mixed first-half financial performance on Tuesday, after group revenue increased 9% year-on-year to £60.4m.
Loungers reports slight slowdown in LFL sales growth
(Sharecast News) - Cosy Club owner Loungers reported a slight slowdown in like-for-like sales growth on Tuesday and a jump in revenue.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.